Condition
Liver cancer due to hepatitis B
Clinical trials and treatment information for Liver cancer due to hepatitis B
Treatment Rankings
Ranked by evidence volume first. Medicine has spent centuries ranking things by vibes. This is an improvement.
Comparative Safety Scale(Higher is safer)
Time to Effect
immediate (tumor removal), long-term survival benefit
Duration
single surgery, lifelong immunosuppression
Response Rate
100%
Remission Rate
100%
Common Side Effects:
Annual Cost of Care
Drug Cost
$15,000
Monitoring
$15,000
Side Effects
$10,000
Total Annual
$40,000
Cost-Effectiveness
MODERATEQALYs Gained
8
ICER
$150,000/QALY
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
immediate (tumor destruction)
Duration
single session, repeat if recurrence
Response Rate
90%
Remission Rate
90%
Common Side Effects:
Annual Cost of Care
Drug Cost
$0
Monitoring
$7,000
Side Effects
$1,000
Total Annual
$8,000
Cost-Effectiveness
EXCELLENTQALYs Gained
4.5
ICER
$40,000/QALY
Cost per Remission
$35,556
Cost per Responder
$35,556
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
immediate (tumor removal)
Duration
single surgery, then surveillance
Response Rate
100%
Remission Rate
100%
Common Side Effects:
Annual Cost of Care
Drug Cost
$0
Monitoring
$7,000
Side Effects
$1,000
Total Annual
$8,000
Cost-Effectiveness
GOODQALYs Gained
4
ICER
$80,000/QALY
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-3 months
Duration
until disease progression or unacceptable toxicity
Response Rate
30%
Remission Rate
8%
Common Side Effects:
Annual Cost of Care
Drug Cost
$264,000
Monitoring
$15,000
Side Effects
$21,000
Total Annual
$300,000
Cost-Effectiveness
POORQALYs Gained
0.8
ICER
$350,000/QALY
Cost per Remission
$3,750,000
Cost per Responder
$1,000,000
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-3 months
Duration
until disease progression or unacceptable toxicity
Response Rate
24%
Remission Rate
1%
Common Side Effects:
Annual Cost of Care
Drug Cost
$216,000
Monitoring
$15,000
Side Effects
$9,000
Total Annual
$240,000
Cost-Effectiveness
POORQALYs Gained
0.6
ICER
$300,000/QALY
Cost per Responder
$1,000,000
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-2 months
Duration
1-3 sessions initially, repeated as needed (every 3-6 months)
Response Rate
60%
Remission Rate
20%
Number Needed to Treat (NNT)
7
Number Needed to Harm (NNH)
15
Common Side Effects:
Annual Cost of Care
Drug Cost
$0
Monitoring
$7,000
Side Effects
$3,000
Total Annual
$10,000
Cost-Effectiveness
GOODQALYs Gained
1
ICER
$80,000/QALY
Cost per Remission
$200,000
Cost per Responder
$66,667
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
1-3 months
Duration
until disease progression or unacceptable toxicity
Response Rate
3%
Remission Rate
1%
Number Needed to Treat (NNT)
12
Common Side Effects:
Annual Cost of Care
Drug Cost
$150,000
Monitoring
$15,000
Side Effects
$5,000
Total Annual
$170,000
Cost-Effectiveness
POORQALYs Gained
0.4
ICER
$180,000/QALY
Cost per Responder
$5,666,667
Clinical Trial Phases: